Clinical trial
An Open-label Study of ALPN-101 in Steroid-resistant or Steroid-refractory Acute Graft Versus Host Disease (aGVHD)
NCT04227938 is registered in ClinicalTrials.gov with Alpine Immune Sciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study of ALPN-101 in Steroid-resistant or Steroid-refractory Acute Graft Versus Host Disease (aGVHD)
- Lead sponsor
- Alpine Immune Sciences, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 11, 2020
- Completion date
- May 21, 2020
- Enrollment
- 1 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.